Vor Biopharma VOR Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vor Biopharma's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vor Biopharma's retained earnings?
- Vor Biopharma (VOR) reported retained earnings of -$1.37B in Q1 2026.
- How has Vor Biopharma's retained earnings changed year-over-year?
- Vor Biopharma's retained earnings decreased by 180.4% year-over-year, from -$489.48M to -$1.37B.
- What is the long-term trend for Vor Biopharma's retained earnings?
- Over 5 years (2020 to 2025), Vor Biopharma's retained earnings has grown at a 79.9% compound annual growth rate (CAGR), from -$61.22M to -$1.15B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.